Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma

Overview of attention for article published in Radiation Oncology, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 15 X posts from 11 X users, with an upper bound of 15,967 followers.

RT @inf_entropy: .Enlace directo al artículo enlazado por @AmadeoWals , para los que nos da problemas linkis ... https://t.co/vQKXXR5Qmb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.